HCP Live

What Does the New Jersey Department of Health have planned to Protect NJ Residents Against Zika Infection?

May 27, 2016

Contagion Editorial Staff

Christina G. Tan, MD, MPH, FACP, New Jersey State Epidemiologist/Assistant Commissioner, provides background on New Jersey Department of Health’s Zika prevention program, ZAP Zika.

Christina G. Tan, MD, MPH, FACP, State Epidemiologist/Assistant Commissioner, Division of Epidemiology, Environmental and Occupational Health, New Jersey Department of Health, provides background on New Jersey Department of Health’s Zika prevention program, ZAP Zika.

Related Videos

Related Content

“A Gamechanger to how Pediatric Care Is Conducted”: RSVpreF Vaccine Could Reduce RSV in Infants by Over 80%

FDA Advisory Committee Affirms Safety and Efficacy of Pfizer RSVpreF Vaccine

The Challenges of Treating RSV in Children…Without a Vaccine

Diagnosis of C difficile Infection (CDI)

Overview of Gut Microbiome

Contextualizing the First RSV Vaccine: How Past Failures Informed Current Successes

“A Gamechanger to how Pediatric Care Is Conducted”: RSVpreF Vaccine Could Reduce RSV in Infants by Over 80%

FDA Advisory Committee Affirms Safety and Efficacy of Pfizer RSVpreF Vaccine

The Challenges of Treating RSV in Children…Without a Vaccine

Diagnosis of C difficile Infection (CDI)

Overview of Gut Microbiome

Contextualizing the First RSV Vaccine: How Past Failures Informed Current Successes

“A Gamechanger to how Pediatric Care Is Conducted”: RSVpreF Vaccine Could Reduce RSV in Infants by Over 80%

FDA Advisory Committee Affirms Safety and Efficacy of Pfizer RSVpreF Vaccine

The Challenges of Treating RSV in Children…Without a Vaccine

Diagnosis of C difficile Infection (CDI)

Overview of Gut Microbiome

Contextualizing the First RSV Vaccine: How Past Failures Informed Current Successes

Related Content

“A Gamechanger to how Pediatric Care Is Conducted”: RSVpreF Vaccine Could Reduce RSV in Infants by Over 80%

“A Gamechanger to how Pediatric Care Is Conducted”: RSVpreF Vaccine Could Reduce RSV in Infants by Over 80%

FDA Advisory Committee Affirms Safety and Efficacy of Pfizer RSVpreF Vaccine

FDA Advisory Committee Affirms Safety and Efficacy of Pfizer RSVpreF Vaccine

The Challenges of Treating RSV in Children…Without a Vaccine

The Challenges of Treating RSV in Children…Without a Vaccine

Diagnosis of C difficile Infection (CDI)

Diagnosis of C difficile Infection (CDI)

Overview of Gut Microbiome

Overview of Gut Microbiome

Contextualizing the First RSV Vaccine: How Past Failures Informed Current Successes

Contextualizing the First RSV Vaccine: How Past Failures Informed Current Successes

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.